维普中文期刊产品整合服务
31篇 您的检索式:作者名="Stoupis"
    题名 作者 年代 出处 被引量
1MR motility imaging in Crohn’s disease improves lesion detection compared with standard MR imaging显示文摘Johannes M. Froehlich Christian Waldherr Christoforos Stoupis S. Mehmet Erturk Michael A. Patak 2010European Radiology2010,,:1
2High-resolution CT findings in mild pulmonary fat embolism显示文摘Malagari K Economopoulos N Stoupis C 2003Chest2003,123,4:1
3Improved technique for pancreatic MRI: value of oblique fat suppression imaging with oral barium administration显示文摘Helmbereger T Mergo PJ Stoupis C 1998J Comput Assist Tomogr1998,22,:1
4Primary liver neoplasms:MR imaging with pathologic correlation显示文摘Powers C Ros PR Stoupis C 0,,:1
5Recurrent biliary cystadenoma: MR imaging appearance 显示文摘Stoupis C Ros PR Dolson DJ 1994J Magn R eson Imaging1994,4,1:1
6High-resolution CT findings in mild pulmonary fat embolism显示文摘Malagari K Economopoulos N Stoupis C 2003Chest2003,123,4:1
7High-resolution CT findings in mild pulmonary fat embolism显示文摘Malagari K Economopoulos N Stoupis C 2003Chest2003,123,4:1
8High-resolution CT findings in mild pulmonary fat embolism显示文摘 Economopoulos N Stoupis C ed al 2003Chest2003,123,4:1
9High-resolution CT findings in mild pulmonary fat embolism显示文摘 Economopoulos N Stoupis C 2003Chest2003,123,4:1
10Inhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin,a synthetic analogue of the tripeptide hemiasterlin显示文摘AIM: To investigate the inhibitory effects of taltobulin (HTI-286), a synthetic analogue of natural hemiasterlin derived from marine sponges, on hepatic tumor growth in vitro and in vivo. METHODS: The potential anti-proliferative effects of HTI-286 on different hepatic tumor cell lines in vitro and in vivo were examined. RESULTS: HTI-286 significantly inhibited proliferation of all three hepatic tumor cell lines (mean IC50 = 2 nmol/L ± 1 nmol/L) in vitro. Interestingly, no decrease in viable primary human hepatocytes (PHH) was detected under HTI-286 exposure. Moreover, intravenous administration of HTI-286 significantly inhibited tumor growth in vivo (rat allograft model). CONCLUSION: HTI-286 might be considered a potent promising drug in treatment of liver malignancies. HTI-286 is currently undergoing clinical evaluation in cancer patients.Yogesh K Vashist Celine Tiffon Christoforos Stoupis Claudio A Redaelli 2006World Journal of Gastroenterology2006,12,42:1
11Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma 显示文摘Piguet AC Semela D Keogh A Wilkens L Stroka D Stoupis C 2008J Hepatol2008,49,1:1
12Primary liver neoplasms:MR imaging with pathologic correlation显示文摘Power C Ros PR Stoupis C 1994Radiographics1994,14,2:1
13In vivo bioavailability, absorption, excretion, and pharmacokinetics of procyanidin B2 in male rats显示文摘Stoupi S Williamson G Viton F 2010Drug Metabolism and Disposition2010,,38:1
14A comparison of the in vitro biotransformation of (-)-epicatechin and procyanidin B2 by human faecal microbiota显示文摘Stoupi S Williamson G Drynan J W 2010Molecular Nutrition & Food Research2010,,54:1
15Estimation of central venous pressure by ultrasound显示文摘Baumann UA Marquis C Stoupis C 2005Resuscitation2005,64,2:1
16Castleman disease mimicking an aggressive retroperitoneal neoplasm显示文摘W. K. Johnson P. R. Ros C. Powers C. Stoupis K. H. Segel 1994Abdominal Imaging1994,,4:1
17The Rocky liver:radiologic-pathologic correlation of calcified hepatic masses显示文摘Stoupis C Taylor HM Paley MR 1998Radiographics1998,18,:1
18Hydrodynamic shear damage of brewer's yeast显示文摘Stoupis T Stewart G G Stafford R A 2003J Am Soc Brew Chem2003,60,4:1
19The rocky liver:radiologic pathologic correlation of calcified hepatic masses显示文摘Stoupis C Taylor HM Paley MR 1998Radiographics1998,18,3:1
20Improved technique for pancreatic MRI:value of oblique fat suppuession imaging with oral barium administr ation显示文摘 Mergo PJ Stoupis C 1998J Comput Assist Tomogr1998,22,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费